<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Duncan Bucknell</title>
	<atom:link href="https://duncanbucknell.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://duncanbucknell.com</link>
	<description>Strategic Intellectual Property</description>
	<lastBuildDate>Mon, 02 Nov 2026 21:51:17 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://i0.wp.com/duncanbucknell.com/wp-content/uploads/2023/06/cropped-DB-logo-1.png?fit=32%2C32&#038;ssl=1</url>
	<title>Duncan Bucknell</title>
	<link>https://duncanbucknell.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">63285024</site>	<item>
		<title>What copycats tell you about your IP: the dupe test for your brand protection strategy</title>
		<link>https://duncanbucknell.com/what-copycats-tell-you-about-your-ip-the-dupe-test-for-your-brand-protection-strategy/</link>
		
		<dc:creator><![CDATA[Duncan]]></dc:creator>
		<pubDate>Wed, 11 Nov 2026 23:30:00 +0000</pubDate>
				<category><![CDATA[Brands and Trade Marks]]></category>
		<category><![CDATA[Copyright and Designs]]></category>
		<category><![CDATA[Enforce and defend your IP]]></category>
		<category><![CDATA[IP Rights]]></category>
		<category><![CDATA[Product Strategy]]></category>
		<category><![CDATA[Risk management]]></category>
		<category><![CDATA[Strategic Advice]]></category>
		<guid isPermaLink="false">https://duncanbucknell.com/?p=16028</guid>

					<description><![CDATA[A copycat is a free audit of your intellectual property. Everything it managed to reproduce is something you did not own, or did not protect well enough. Everything it had to leave out is where your real advantage sits. Most brand protection strategies start from the first list. The second list is where the value is. An article in Harvard Business Review by Graham Kenny and Ganna Pogrebna makes the business case... <a class="read-more" href="https://duncanbucknell.com/what-copycats-tell-you-about-your-ip-the-dupe-test-for-your-brand-protection-strategy/">Read More</a>]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">A copycat is a free audit of your intellectual property. Everything it managed to reproduce is something you did not own, or did not protect well enough. Everything it had to leave out is where your real advantage sits. Most brand protection strategies start from the first list. The second list is where the value is.</p>



<p class="wp-block-paragraph">An article in Harvard Business Review by Graham Kenny and Ganna Pogrebna makes the business case with three examples. Lululemon invited owners of imitation leggings to swap them for the real thing, and about half of the thousand people who turned up were new customers. Swatch and Omega built their own low-priced version of the much-copied Speedmaster, and sales of the US$7,000 original rose by more than half. Cluely, an AI startup, saw a free open-source clone of its product within weeks, and moved to enterprise features a lone developer could not reproduce. The authors&#8217; instruction is to &#8220;treat imitation as a mirror&#8221;.</p>



<h2 class="wp-block-heading">What the copy could not carry</h2>



<p class="wp-block-paragraph">Read those cases as an IP owner and one pattern appears. What the imitator could not copy was a protected asset.</p>



<p class="wp-block-paragraph">– The dupe leggings copied the cut and the feel of the fabric. They could not use the Lululemon name. Lululemon has since registered DUPE SWAP and LULULEMON DUPE as trade marks in the United States, so the word the market uses to find a copy now points back to the original. Where a lookalike crosses into its protected designs, it sues, as it did against Costco last year.</p>



<p class="wp-block-paragraph">– The homage watches copied a design from 1957, long past any registered protection. They could not put Omega on the dial. Swatch sold authenticity, which is a trade mark, for about US$260. <a href="https://duncanbucknell.com/when-the-monopoly-ends-your-shape-has-to-stand-on-its-own/">When the Monopoly Ends, Your Shape Has to Stand on Its Own</a> shows what happens when the shape has to carry that weight alone.</p>



<p class="wp-block-paragraph">– The clone copied a software feature in days. It could not copy customer contracts, security controls, integrations or accumulated data. Those are trade secrets, contracts and sometimes patents, the question asked in <a href="https://duncanbucknell.com/when-anyone-can-build-it-in-an-afternoon-whats-left-to-own/">When Anyone Can Build It in an Afternoon, What&#8217;s Left to Own?</a>.</p>



<p class="wp-block-paragraph">The authors propose an audit: list what was copied and what was not. The IP version adds a third column. For each item the copy could not carry, name the right that protects it and ask whether it is registered, documented and enforceable. A reputation in a product&#8217;s look that was never registered as a design or a trade mark is passing-off evidence waiting to be assembled. A process that lives in engineers&#8217; heads is not a trade secret.</p>



<p class="wp-block-paragraph">Two moves follow. Where the copy reveals a segment the premium product never served, serve it under your own mark, as Swatch did, and the imitator loses its one advantage. That is the question <a href="https://duncanbucknell.com/butterfly-effect-and-ip-mimicry/">Butterfly Effect and IP Mimicry</a> raised in 2011. And where the thing copied cannot be protected at all, stop spending on its defence and move the investment to what remains hard to reproduce.</p>



<p class="wp-block-paragraph">Before the next launch, ask what a competent copycat would take, and whether what is left is something you can enforce. If it is not, the copycat&#8217;s list is your filing list, and your brand protection strategy starts there.</p>



<p class="wp-block-paragraph">Read the article: <a href="https://hbr.org/2026/10/how-copycats-can-reveal-your-competitive-advantage">How Copycats Can Reveal Your Competitive Advantage</a>, Graham Kenny and Ganna Pogrebna, Harvard Business Review.</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">16028</post-id>	</item>
		<item>
		<title>Who keeps the IP in a carve-out? The ownership decision that shapes both companies</title>
		<link>https://duncanbucknell.com/who-keeps-the-ip-in-a-carve-out-the-ownership-decision-that-shapes-both-companies/</link>
		
		<dc:creator><![CDATA[Duncan]]></dc:creator>
		<pubDate>Mon, 09 Nov 2026 23:30:00 +0000</pubDate>
				<category><![CDATA[Commercial IP, deals and contracts]]></category>
		<category><![CDATA[Increase IP Value]]></category>
		<category><![CDATA[Risk management]]></category>
		<category><![CDATA[Strategic Advice]]></category>
		<category><![CDATA[Trade Secrets]]></category>
		<guid isPermaLink="false">https://duncanbucknell.com/?p=16041</guid>

					<description><![CDATA[When a company splits in two, one side usually ends up renting what it used to own. Which side, and on what terms, is decided in the separation workstream that gets the least board attention: the allocation of patents, brands, data and know-how. That allocation then sets the limits of what either company can become. A BCG analysis published recently makes the business case for treating a carve-out as a redesign of... <a class="read-more" href="https://duncanbucknell.com/who-keeps-the-ip-in-a-carve-out-the-ownership-decision-that-shapes-both-companies/">Read More</a>]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">When a company splits in two, one side usually ends up renting what it used to own. Which side, and on what terms, is decided in the separation workstream that gets the least board attention: the allocation of patents, brands, data and know-how. That allocation then sets the limits of what either company can become.</p>



<p class="wp-block-paragraph">A BCG analysis published recently makes the business case for treating a carve-out as a redesign of both companies, not just the one being sold. Its data says carve-outs paired with a full transformation programme outperformed conventional separations by 20.3 percentage points of total shareholder return over two years. Its warning is that the continuing company usually gets a clean-up exercise while the new company gets the strategy. The line to keep: &#8220;Rationalization optimizes the inherited model; it does not determine whether that model remains the right one.&#8221;</p>



<p class="wp-block-paragraph">The authors note that transitional services agreement design can constrain future systems choices. The same is true, with more force, for the IP split, which the article does not discuss.</p>



<h2 class="wp-block-heading">The carve-out IP ownership test</h2>



<p class="wp-block-paragraph">Every shared asset in a separation gets one of three fates: it goes with the new company, it stays with the continuing company, or it is licensed across. The third option is the easy one at the deal table and the costly one afterwards. Three consequences follow.</p>



<p class="wp-block-paragraph">– A licence fixes the strategy of the licensee. A new company that holds its core technology under licence from its former parent cannot enter fields, territories or product lines the licence excludes, and cannot sell or raise capital on a platform it does not own. The parent&#8217;s constraints become its own. <a href="https://duncanbucknell.com/who-owns-the-design-why-ip-ownership-is-often-a-condition-of-winning-the-contract/">Who Owns the Design? Why IP Ownership Is often a Condition of Winning the Contract</a> shows how a licence signed years earlier decides which contracts a company may bid for.</p>



<p class="wp-block-paragraph">– A licence fixes the economics of the licensor. A continuing company that keeps the patents but licenses them to a business that now competes with it has priced its own competitor&#8217;s inputs. Those terms will be tested the first time either side changes direction, which is the point made in <a href="https://duncanbucknell.com/who-sets-the-price-of-your-ip-why-the-licence-decides-not-the-patent/">Who sets the price of your IP? Why the licence decides, not the patent</a>.</p>



<p class="wp-block-paragraph">– Data and know-how do not split cleanly. Customer data, process know-how and trained models sit in shared systems, and the TSA that keeps them running keeps them shared. Whichever company is meant to own them needs ownership documented, access controlled and confidentiality running the other way before Day 1, or the trade secret is lost in the handover.</p>



<p class="wp-block-paragraph">The practical move is to allocate IP with the strategy, not after it. For each business, decide what it must own outright to pursue its planned position, and assign those rights before the TSA and the systems choices lock the arrangement in. The question in <a href="https://duncanbucknell.com/does-your-ai-strategy-move-you-or-just-add-a-feature-the-ip-test-for-platform-partnerships/">Does your AI strategy move you, or just add a feature? The IP test for platform partnerships</a> applies without change: after this move, what will each company control that it did not control before.</p>



<p class="wp-block-paragraph">A carve-out that leaves one company dependent on the other has not created two businesses. It has created a licensor and a licensee, and the transformation each is promised will stop at the edge of the licence.</p>



<p class="wp-block-paragraph">Read the article: <a href="https://www.bcg.com/publications/2026/carve-out-strategy-both-companies">Better Apart: When a Carve-Out Transforms Both Companies</a>, Jared Feiger, Simon Weinstein, Georg Keienburg, Nidhi Meppadan and Dominik Degen, BCG.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">16041</post-id>	</item>
		<item>
		<title>Valid but not infringed: what OrthAlign v Navbit means for your patent claims</title>
		<link>https://duncanbucknell.com/valid-but-not-infringed-what-orthalign-v-navbit-means-for-your-patent-claims/</link>
		
		<dc:creator><![CDATA[Duncan]]></dc:creator>
		<pubDate>Wed, 04 Nov 2026 23:30:00 +0000</pubDate>
				<category><![CDATA[Develop IP]]></category>
		<category><![CDATA[Disputes and Litigation]]></category>
		<category><![CDATA[Enforce and defend your IP]]></category>
		<category><![CDATA[Inventions & Patents]]></category>
		<category><![CDATA[IP Rights]]></category>
		<category><![CDATA[Strategic Advice]]></category>
		<guid isPermaLink="false">https://duncanbucknell.com/?p=16032</guid>

					<description><![CDATA[A patent that survives every attack on its validity can still be worth nothing against the competitor you sued. Whether it covers them is decided by the words of the claims, and in Australia those words are read as written. Close is not enough. That is what happened last month in the Federal Court. OrthAlign, a US surgical navigation company, sued Sydney&#8217;s Navbit over a device that guides the placement of an... <a class="read-more" href="https://duncanbucknell.com/valid-but-not-infringed-what-orthalign-v-navbit-means-for-your-patent-claims/">Read More</a>]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">A patent that survives every attack on its validity can still be worth nothing against the competitor you sued. Whether it covers them is decided by the words of the claims, and in Australia those words are read as written. Close is not enough.</p>



<p class="wp-block-paragraph">That is what happened last month in the Federal Court. OrthAlign, a US surgical navigation company, sued Sydney&#8217;s Navbit over a device that guides the placement of an artificial hip socket. Navbit counter-attacked the patent on four grounds. Every ground failed. The patent stood. It simply did not reach the product.</p>



<p class="wp-block-paragraph">Claim 1 required a clamp with a channel &#8220;comprising a round inner surface configured to receive a round outer surface of the impactor&#8221;. Navbit&#8217;s clamp grips the impactor shaft on the flat sides of a V. The rounded part at the base of the V never touches the shaft. One feature missing, so no infringement. The court applied the settled Australian rule that the form and wording of the claim are determinative, and OrthAlign did not argue that Navbit&#8217;s clamp was a mechanical equivalent.</p>



<p class="wp-block-paragraph">The strategic point is in why that feature was there. The specification described a &#8220;universal&#8221; adapter that could fit a range of impactor shafts. Both experts agreed a V-shaped clamp is the natural way to grip shafts of different diameters. The claim did not say that. It described the rounded shape in the drawing. The competitor built the function and avoided the shape.</p>



<p class="wp-block-paragraph">The cost was four years of litigation on an innovation patent that expired seven months before judgment, with the question of costs still to come.</p>



<h2 class="wp-block-heading">Claim the function, then test the design around</h2>



<p class="wp-block-paragraph">Three disciplines follow for anyone who files patents to keep competitors out of a market.</p>



<p class="wp-block-paragraph">– Claim what the invention does, not what the drawing shows. Where the point of the invention is to fit a range, grip a range or handle a range, the independent claim has to say so. The illustrated shape belongs in a dependent claim as a fallback.</p>



<p class="wp-block-paragraph">– Before filing, and again before suing, hand the claims to an engineer with one instruction: avoid them. If the obvious workaround still delivers the customer benefit, the claim is a description of your product, not a monopoly over the market. That is the &#8220;insufficiently broad&#8221; test in <a href="https://duncanbucknell.com/ip-due-diligence-put-simply-with-the-6-ts-framework/">IP Due Diligence – put simply – with the 6 Ts framework</a>, applied to your own portfolio.</p>



<p class="wp-block-paragraph">– Before suing, match the accused product to every integer of the claim, with the product in hand. <a href="https://duncanbucknell.com/tangling-in-your-own-pre-litigation-strategy/">Tangling in your pre-litigation strategy</a> sets out how to reduce that uncertainty before proceedings start.</p>



<p class="wp-block-paragraph">None of this means claim everything. <a href="https://duncanbucknell.com/when-your-own-words-become-your-cage-the-cost-of-claim-drafting-choices/">When Your Own Words Become Your Cage: The Cost of Claim Drafting Choices</a> shows the other edge: a claim wider than the specification supports fails for a different reason. The skill is a claim set that is as broad as the disclosure allows at the top, with the drawings carried underneath.</p>



<p class="wp-block-paragraph">The board question is not &#8220;do we have a patent&#8221;. It is &#8220;if a competent engineer were paid to design around our claims, how long would it take and what would the customer lose&#8221;. If the answer is a few weeks and nothing, the patent is paperwork.</p>



<p class="wp-block-paragraph">Read the judgment: <a href="https://www.judgments.fedcourt.gov.au/judgments/Judgments/fca/single/2026/2026fca1542">OrthAlign, Inc v Navbit Pty Ltd [2026] FCA 1542</a>, Federal Court of Australia.</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">16032</post-id>	</item>
		<item>
		<title>Owning It Is Not Controlling It</title>
		<link>https://duncanbucknell.com/owning-it-is-not-controlling-it/</link>
		
		<dc:creator><![CDATA[Duncan]]></dc:creator>
		<pubDate>Mon, 02 Nov 2026 23:30:00 +0000</pubDate>
				<category><![CDATA[Commercial IP, deals and contracts]]></category>
		<category><![CDATA[Increase IP Value]]></category>
		<category><![CDATA[Inform and improve your IP Strategy]]></category>
		<category><![CDATA[Inventions & Patents]]></category>
		<category><![CDATA[Strategic Advice]]></category>
		<category><![CDATA[Trade Secrets]]></category>
		<guid isPermaLink="false">https://duncanbucknell.com/?p=16045</guid>

					<description><![CDATA[October was a month about the gap between owning a right and controlling an outcome. A valid patent on a drug&#8217;s mechanism that left its owner with no market. A licence signed years ago that now decides which defence contracts a company may bid for. A US$4.7 trillion profit shift that goes to whoever holds something a competitor cannot copy, which is rarely the model and rarely the product. Nine posts published... <a class="read-more" href="https://duncanbucknell.com/owning-it-is-not-controlling-it/">Read More</a>]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">October was a month about the gap between owning a right and controlling an outcome.</p>



<p class="wp-block-paragraph">A valid patent on a drug&#8217;s mechanism that left its owner with no market. A licence signed years ago that now decides which defence contracts a company may bid for. A US$4.7 trillion profit shift that goes to whoever holds something a competitor cannot copy, which is rarely the model and rarely the product.</p>



<p class="wp-block-paragraph">Nine posts published this month fall into three groups: what the contract decides, why owning the invention is not the same as owning the market, and what is left to protect when the capability itself is cheap. Read together they make one point from three directions. The grant, the licence and the filing are instruments. Control is the result, and it is decided elsewhere.</p>



<h2 class="wp-block-heading">The contract decides what you control</h2>



<p class="wp-block-paragraph"><a href="https://duncanbucknell.com/who-sets-the-price-of-your-ip-why-the-licence-decides-not-the-patent/">The licence, not the patent, sets the price</a>. The UK dropped its plan to set royalties on standard essential patents, a Delaware jury found Arm in breach of its Qualcomm architecture licence and awarded two dollars, and Liquidia paid US$380.7 million to keep the larger market while surrendering one indication. In each, the value sat in terms settled long before anyone reached a court.</p>



<p class="wp-block-paragraph">The same terms decide market access. In India&#8217;s draft defence procurement rules, <a href="https://duncanbucknell.com/who-owns-the-design-why-ip-ownership-is-often-a-condition-of-winning-the-contract/">IP ownership is a condition of winning the contract</a>: a vendor that holds its design data under a foreign licence cannot bid. An inbound licence is a market-access document, and chain of title is a tender question.</p>



<p class="wp-block-paragraph">Two posts applied the test to AI. When a company adds AI to a product, the useful question is whether <a href="https://duncanbucknell.com/does-your-ai-strategy-move-you-or-just-add-a-feature-the-ip-test-for-platform-partnerships/">the move changes what it controls</a> – the interface, the data, the customer relationship – or just adds a feature on a platform someone else owns. And as frontier models get cheaper, the buyer should ask <a href="https://duncanbucknell.com/if-the-model-is-free-what-are-you-actually-buying-an-ip-strategy-question-for-ai-buyers/">what it is actually buying</a>, because the model layer confers no exclusivity. Keep the contracts flexible, plan for a model disappearing, and put the protection around your own data and workflows.</p>



<h2 class="wp-block-heading">Owning the invention is not owning the market</h2>



<p class="wp-block-paragraph">A failed clinical trial made the sharpest version of the point. A patent covers a mechanism, not the benefit the mechanism delivers, and where the existing standard of care already captures that benefit, <a href="https://duncanbucknell.com/owning-the-mechanism-is-not-a-position-what-a-failed-trial-says-about-patent-strategy/">owning the mechanism is not a position</a>. Value rights against the incumbent default, and secure the combination claims early.</p>



<p class="wp-block-paragraph">China&#8217;s energy plans showed the industrial version. Control of manufacturing and deployment capacity can matter as much as the invention, so <a href="https://duncanbucknell.com/who-gets-to-scale-it-what-chinas-energy-plans-say-about-your-patent-filing-strategy/">who gets to scale it</a> is a filing question: file where the product is made and installed, protect the process know-how, and read the supply contracts for IP terms.</p>



<p class="wp-block-paragraph">For challengers, the lesson is timing. A better business model buys a window, not a barrier, and <a href="https://duncanbucknell.com/better-buys-time-not-a-barrier-what-counter-positioning-means-for-your-patent-strategy/">counter-positioning</a> only converts into a durable position if the core mechanism is filed before the incumbent studies it or a second startup arrives without the incumbent&#8217;s constraints.</p>



<h2 class="wp-block-heading">What is left to protect when the capability is cheap</h2>



<p class="wp-block-paragraph">Bain&#8217;s estimate that AI will move US$4.7 trillion in profit by 2035 raises the question of who keeps it. Only a quarter is productivity, which every competitor gets too. The rest goes to whoever <a href="https://duncanbucknell.com/who-keeps-the-profit-when-ai-makes-the-product-the-trade-secret-test-for-your-ai-strategy/">owns something others cannot copy</a>: trade secrets over the data and operating know-how, patents over the methods a rival could reach independently.</p>



<p class="wp-block-paragraph">And whatever the asset is, it is worth what can be proved. IBM&#8217;s quantum result was built so the answer could be verified while it ran, and was challenged within days anyway. A company trading on a technical edge should expect the same test from an examiner, a court or an acquirer, which is why <a href="https://duncanbucknell.com/can-you-prove-your-technical-lead-what-ibms-verifiable-quantum-advantage-means-for-your-patent-strategy/">a lead you cannot prove is a lead you do not own</a>.</p>



<h2 class="wp-block-heading">What to watch</h2>



<p class="wp-block-paragraph">The thread through October is that the decisive document is rarely the one with the seal on it. It is the licence, the supply contract, the partnership terms and the evidence record, and those are written while the business is still deciding what it wants to control.</p>



<p class="wp-block-paragraph">Three things are worth watching as the year closes. The Arm and Qualcomm royalty question goes to the judge next, and will show what a single licence obligation is worth. The UK&#8217;s court-anchored FRAND process will set the template for how standards royalties get negotiated without a regulator. And the AI contracts being signed now, as model prices fall, will decide who owns the data and workflows that the Bain profit shift rewards.</p>



<p class="wp-block-paragraph">The question for the next strategy review is not what the company owns. It is what, after each deal and each filing, it actually controls – and whether the documents say the same.</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">16045</post-id>	</item>
		<item>
		<title>Who Owns the Design? Why IP Ownership Is often a Condition of Winning the Contract</title>
		<link>https://duncanbucknell.com/who-owns-the-design-why-ip-ownership-is-often-a-condition-of-winning-the-contract/</link>
		
		<dc:creator><![CDATA[Duncan]]></dc:creator>
		<pubDate>Sun, 25 Oct 2026 23:30:00 +0000</pubDate>
				<category><![CDATA[Commercial IP, deals and contracts]]></category>
		<category><![CDATA[Inform and improve your IP Strategy]]></category>
		<category><![CDATA[Product Strategy]]></category>
		<category><![CDATA[Risk management]]></category>
		<guid isPermaLink="false">https://duncanbucknell.com/?p=15914</guid>

					<description><![CDATA[Many companies treat IP ownership as something settled after a contract is won. However, a buyer large enough to set the terms can make ownership a condition of bidding. When that happens, the licence you signed five years ago quietly decides which contracts you are allowed to compete for. India&#8217;s Ministry of Defence has put out for consultation a draft acquisition procedure that does exactly this. Writing for ETGovernment, Major General Rajan... <a class="read-more" href="https://duncanbucknell.com/who-owns-the-design-why-ip-ownership-is-often-a-condition-of-winning-the-contract/">Read More</a>]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Many companies treat IP ownership as something settled after a contract is won. However, a buyer large enough to set the terms can make ownership a condition of bidding. When that happens, the licence you signed five years ago quietly decides which contracts you are allowed to compete for.</p>



<p class="wp-block-paragraph">India&#8217;s Ministry of Defence has put out for consultation a draft acquisition procedure that does exactly this. Writing for ETGovernment, Major General Rajan Kochhar (Retd) reads the shift as doctrinal rather than procedural. The question moves from where equipment is manufactured to who owns the technology, and procurement preferences increasingly favour bidders holding indigenous IP and design authority. Reporting on the draft indicates that to qualify as indigenously designed, a vendor must own not just the finished system but the underlying source code and design data, together with the right to modify and upgrade without encumbrance. Design licences from foreign manufacturers do not satisfy that test.</p>



<p class="wp-block-paragraph">Kochhar is careful that this is a proposal, and that its worth will turn on enforcement rather than drafting. The direction is the point.</p>



<h3 class="wp-block-heading">IP ownership as a gate to putting in a bid</h3>



<p class="wp-block-paragraph">Ownership has moved upstream. It used to be a term you negotiated after selection. Increasingly it is a gate you pass before you are allowed to bid at all. Three consequences follow, and none of them are specific to defence.</p>



<p class="wp-block-paragraph">– Read your inbound licences as market-access documents, not cost items. Field-of-use limits, consent-to-modify clauses and third-party transfer restrictions decide which customers you can serve, the same point I made about downloadable models in <a href="https://duncanbucknell.com/when-everyone-can-run-the-model-what-open-weight-ai-means-for-your-ip-strateg/">When Everyone Can Run the Model: What Open-Weight AI Means for Your IP Strategy</a>.</p>



<p class="wp-block-paragraph">– Treat design authority as an evidentiary claim. Ask what you could actually prove under scrutiny: chain of title, assignments from contractors and subcontractors, records of who wrote the code. Most companies find this out during a tender, which is the worst moment to find it out.</p>



<p class="wp-block-paragraph">– Settle ownership in the agreement, before the work starts. Ownership rests on what the contract says rather than on who runs the factory, which is the mechanism underneath <a href="https://duncanbucknell.com/why-costcos-90b-kirkland-empire-is-really-an-ip-strategy-in-disguise/">Why Costco&#8217;s $90B &#8220;Kirkland&#8221; Empire Is Really an IP Strategy in Disguise</a>.</p>



<p class="wp-block-paragraph">Leverage runs one way here. It moves to the licensor the moment your capital is committed, which is why an in-licence has to be priced before the plant is built, not after – the trap in <a href="https://duncanbucknell.com/capacity-is-not-a-moat-what-indias-electrification-build-out-means-for-your-ip-strategy/">Capacity Is Not a Moat: What India&#8217;s Electrification Build-Out Means for Your IP Strategy</a>. There is an export dimension too. Buyers hesitate to take a system whose upgrade authority sits in a third country, because the seller cannot promise support without someone else&#8217;s permission. Ownership is not only a margin question. It is permission to sell.</p>



<p class="wp-block-paragraph">So the useful question is not whether you own your IP. It is narrower and harder. If your largest customer scored your bid based on IP ownership tomorrow, which of your contracts would cost you the work?</p>



<p class="wp-block-paragraph">Read the article: <a href="https://government.economictimes.indiatimes.com/amp/blog/dap-2026-why-owning-ip-is-the-key-to-indias-defence-sovereignty/133063249">DAP 2026: Why owning IP is the key to India&#8217;s defence sovereignty</a>, Major General Rajan Kochhar (Retd), ETGovernment.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">15914</post-id>	</item>
		<item>
		<title>Better buys time, not a barrier: what counter-positioning means for your patent strategy</title>
		<link>https://duncanbucknell.com/better-buys-time-not-a-barrier-what-counter-positioning-means-for-your-patent-strategy/</link>
		
		<dc:creator><![CDATA[Duncan]]></dc:creator>
		<pubDate>Wed, 21 Oct 2026 23:30:00 +0000</pubDate>
				<category><![CDATA[Pursue Excellence]]></category>
		<guid isPermaLink="false">https://duncanbucknell.com/?p=15961</guid>

					<description><![CDATA[A better product buys a challenger time. It does not buy a barrier. The mistake most founders make is treating the time as the win, and spending the whole of it on growth while the one thing that would outlast the window – an exclusive right – goes unfiled. Packy McCormick&#8217;s essay in Not Boring makes the first half of that argument well. Drawing on Hamilton Helmer&#8217;s 7 Powers, he describes counter-positioning:... <a class="read-more" href="https://duncanbucknell.com/better-buys-time-not-a-barrier-what-counter-positioning-means-for-your-patent-strategy/">Read More</a>]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">A better product buys a challenger time. It does not buy a barrier. The mistake most founders make is treating the time as the win, and spending the whole of it on growth while the one thing that would outlast the window – an exclusive right – goes unfiled.</p>



<p class="wp-block-paragraph">Packy McCormick&#8217;s essay in Not Boring makes the first half of that argument well. Drawing on Hamilton Helmer&#8217;s 7 Powers, he describes counter-positioning: a business model the incumbent can see is better but cannot copy without damaging the business it already has. Dell sold direct while Compaq depended on dealers. Amazon shipped from warehouses while Barnes &amp; Noble&#8217;s capital sat in stores. The line to keep is this: &#8220;Better is a benefit; Power requires a barrier.&#8221;</p>



<p class="wp-block-paragraph">The essay is equally clear that the barrier is temporary. Counter-positioning is a take-off phase power. The incumbent eventually restructures, or a second startup arrives with no legacy business to protect. In McCormick&#8217;s words, &#8220;you need to use that time to sprint like hell until you can establish your long-term moats.&#8221;</p>



<p class="wp-block-paragraph"><strong>Where the durable barrier comes from</strong></p>



<p class="wp-block-paragraph">He lists the durable powers a challenger should be building toward: scale economies, network effects, switching costs, cornered resources, process power and brand. The essay does not mention patents, and that is the gap worth filling. Three of those six powers are, in practice, IP positions:</p>



<p class="wp-block-paragraph">– A cornered resource is very often an exclusive right – a patent on the mechanism that makes the model work, an exclusive licence to the input nobody else can source, or a registered brand.<br>– Switching costs are strongest when the thing the customer would have to give up is protected – the data format, the integration, the interface that only you can lawfully supply.<br>– Process power is trade secret discipline by another name. It only counts as a barrier if the process is documented, kept confidential and contractually locked down.</p>



<p class="wp-block-paragraph">The timing matters more than the choice. The counter-positioning window is the only period in which a challenger can file on its core mechanism before the incumbent has studied it closely and before a fast follower has published something similar. Once the window closes, the challenger&#8217;s own success is the prior art. That is the pattern in <a href="https://duncanbucknell.com/why-wait-and-see-is-becoming-the-most-expensive-ip-decision-you-can-make/">Why &#8220;Wait and See&#8221; Is Becoming the Most Expensive IP Decision You Can Make</a>, and it is why <a href="https://duncanbucknell.com/be-prepared-before-you-engage-zest-labs-walmat-and-222m-in-damages/">Be prepared before you engage: Zest Labs, Walmat and $222m in damages</a> ends the way it does: file before the incumbent gets to look inside.</p>



<p class="wp-block-paragraph">The essay&#8217;s own reminder that counter-positioning does not protect you from another startup is the sharpest reason to act. A competing entrant has none of the incumbent&#8217;s conflicted incentives. The only thing that stops it copying the mechanism is a right you can enforce against it. <a href="https://duncanbucknell.com/when-anyone-can-build-it-in-an-afternoon-whats-left-to-own/">When Anyone Can Build It in an Afternoon, What&#8217;s Left to Own?</a> asks the same question from the AI side.</p>



<p class="wp-block-paragraph">For a founder or a board, the practical test is simple. Name the mechanism the incumbent cannot copy. Then ask what stops the next startup copying it, and whether that answer is a filing date or a hope.</p>



<p class="wp-block-paragraph">Read the article: <a href="https://www.notboring.co/p/an-ode-to-counter-positioning">An Ode to Counter-Positioning</a>, Packy McCormick, Not Boring.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">15961</post-id>	</item>
		<item>
		<title>If the Model Is Free, What Are You Actually Buying? An IP Strategy Question for AI Buyers</title>
		<link>https://duncanbucknell.com/if-the-model-is-free-what-are-you-actually-buying-an-ip-strategy-question-for-ai-buyers/</link>
		
		<dc:creator><![CDATA[Duncan]]></dc:creator>
		<pubDate>Sun, 18 Oct 2026 23:30:00 +0000</pubDate>
				<category><![CDATA[Commercial IP, deals and contracts]]></category>
		<category><![CDATA[Develop IP]]></category>
		<category><![CDATA[Increase IP Value]]></category>
		<category><![CDATA[IP Rights]]></category>
		<category><![CDATA[Pursue Excellence]]></category>
		<category><![CDATA[Strategic Advice]]></category>
		<category><![CDATA[Trade Secrets]]></category>
		<guid isPermaLink="false">https://duncanbucknell.com/?p=15906</guid>

					<description><![CDATA[The price of frontier AI capability is falling towards zero. The consequence for an IP strategy is not that AI has become cheaper. It is that anything you thought you were buying at the model layer, you are not buying exclusively. In July a Chinese lab released a model, free to use, that appeared to rival the paid frontier models from the large US developers. When the weights were published a week... <a class="read-more" href="https://duncanbucknell.com/if-the-model-is-free-what-are-you-actually-buying-an-ip-strategy-question-for-ai-buyers/">Read More</a>]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The price of frontier AI capability is falling towards zero. The consequence for an IP strategy is not that AI has become cheaper. It is that anything you thought you were buying at the model layer, you are not buying exclusively.</p>



<p class="wp-block-paragraph">In July a Chinese lab released a model, free to use, that appeared to rival the paid frontier models from the large US developers. When the weights were published a week later, they came under the developer&#8217;s own bespoke licence rather than a standard open-source one. American companies had one less reason to pay for a model, and Washington had a problem it has not resolved. Part of the response has been a pre-release security review for frontier models, which one former official described as a licensing regime for frontier AI in all but name, on top of earlier measures aimed at stopping Chinese developers training on the outputs of US models.</p>



<p class="wp-block-paragraph">Strip out the politics and a control-point question is left, and it is the same one that arrives whenever a capability becomes broadly available. If everyone can run the model, <a href="https://duncanbucknell.com/when-anyone-can-build-it-in-an-afternoon-whats-left-to-own/">what is left to own?</a></p>



<h3 class="wp-block-heading">Four IP strategy questions for anyone buying AI</h3>



<p class="wp-block-paragraph">– Are you paying for exclusivity at the model layer? You are not getting it. Price and term your AI contracts on the assumption the underlying capability keeps getting cheaper. Short terms, benchmarked pricing, and a right to take your prompts, evaluations and fine-tuned weights with you.</p>



<p class="wp-block-paragraph">– Have you read the licence, rather than the label? Open weights are not open source, as I set out in <a href="https://duncanbucknell.com/when-everyone-can-run-the-model-what-open-weight-ai-means-for-your-ip-strateg/">When Everyone Can Run the Model</a>. Bespoke licences carry attribution triggers, revenue thresholds, field-of-use limits and acceptable-use terms, and all of them travel with the weights into your product. That is a freedom-to-operate question for your business, not a procurement footnote.</p>



<p class="wp-block-paragraph">– What happens if the model becomes unavailable? Export controls, release reviews and pressure not to use particular vendors make the right to deploy a regulatory variable rather than a commercial one. Any architecture only one model can serve is a dependency, and it belongs in the risk register with a substitution plan beside it.</p>



<p class="wp-block-paragraph">– What have you captured at the layers that do not commoditise? Your proprietary data, the workflow your customer actually works in, your evaluations and your domain-specific tuning. In most companies these exist as undocumented practice rather than as filings, controlled trade secrets or contract terms.</p>



<p class="wp-block-paragraph">None of that is new, and none of it is specific to AI. Value moves to whatever stays scarce when the headline capability does not, which is the argument in <a href="https://duncanbucknell.com/ai-isnt-your-advantage-your-ip-strategy-is/">AI Isn&#8217;t Your Advantage—Your IP Strategy Is</a>. So the question for your next strategy review is not which model is best this quarter. It is what your business still owns on the morning the model you rely on becomes free to everyone, or unavailable to you.</p>



<p class="wp-block-paragraph">Read the article: <a href="https://www.technologyreview.com/2026/07/20/1140675/chinas-ai-models-have-trumps-ai-world-at-war-with-itself/">China&#8217;s AI models have Trump&#8217;s AI world at war with itself</a>, James O&#8217;Donnell, MIT Technology Review.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">15906</post-id>	</item>
		<item>
		<title>Who sets the price of your IP? Why the licence decides, not the patent</title>
		<link>https://duncanbucknell.com/who-sets-the-price-of-your-ip-why-the-licence-decides-not-the-patent/</link>
		
		<dc:creator><![CDATA[Duncan]]></dc:creator>
		<pubDate>Thu, 15 Oct 2026 22:54:46 +0000</pubDate>
				<category><![CDATA[Commercial IP, deals and contracts]]></category>
		<category><![CDATA[Disputes and Litigation]]></category>
		<category><![CDATA[Increase IP Value]]></category>
		<category><![CDATA[Inventions & Patents]]></category>
		<guid isPermaLink="false">https://duncanbucknell.com/?p=16005</guid>

					<description><![CDATA[The patent is rarely where the money is decided. The licence is. Three IP developments from the past week make that point, and each turns on terms settled, or left unsettled, long before anyone reached a court. In the United Kingdom, the government has published its response to its consultation on standard essential patents, the patents behind 5G, Wi-Fi and similar standards. It has dropped the proposed rate-setting track and an official... <a class="read-more" href="https://duncanbucknell.com/who-sets-the-price-of-your-ip-why-the-licence-decides-not-the-patent/">Read More</a>]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">The patent is rarely where the money is decided. The licence is. Three IP developments from the past week make that point, and each turns on terms settled, or left unsettled, long before anyone reached a court.</p>



<p class="wp-block-paragraph">In the United Kingdom, the government has <a href="https://www.gov.uk/government/news/government-sets-out-next-steps-on-standard-essential-patents">published its response</a> to its consultation on standard essential patents, the patents behind 5G, Wi-Fi and similar standards. It has dropped the proposed rate-setting track and an official essentiality-checking service, and it will not restrict injunctions. What survives is work on an early, court-anchored FRAND determination, a possible IPO opinion service and good-faith negotiation guidance. For any business that builds on standards, the signal is plain. No regulator will set your royalty. The rate will be reached by negotiation, backed by a court, and the party with the better-documented conduct starts ahead. The UK courts were already the venue to watch, as <a href="https://duncanbucknell.com/ip-update-ipr-is-tough-for-older-patents-eu-colour-marks-tesla-final-appeal-in-uk-on-frand-epo-prior-art-clarified/">Tesla’s FRAND appeal</a> showed.</p>



<p class="wp-block-paragraph">In Delaware, a jury found that <a href="https://www.cnbc.com/2026/10/13/delaware-jury-qualcomm-arm-license-agreement.html">Arm breached its architecture licence with Qualcomm</a> and interfered with Qualcomm’s relationship with Meta, then awarded two dollars. The headline is not the number. The breach finding opens the question whether Qualcomm can suspend royalties for five years under a clause Arm says is unenforceable. The judge decides that next. One obligation about software patches and tools may move billions. A licence is a set of promises, each with a price attached, waiting for the day one is tested.</p>



<p class="wp-block-paragraph">In pharmaceuticals, Liquidia agreed to pay United Therapeutics a net <a href="https://www.sec.gov/Archives/edgar/data/0001819576/000110465926115672/tm2627557d1_ex99-1.htm">US$380.7 million</a> after losing on one patent covering inhaled treprostinil for a single lung condition. It will not appeal, it is removing that indication from its label, and it has given covenants that run to 2042. Its shares rose about 40 per cent. The market paid for certainty, bought with structure: one indication surrendered, the larger PAH market kept, payments staged against sales. For the patent owner, one well-aimed claim on a specific use did the work of a portfolio.</p>



<h3 class="wp-block-heading">What this means for your IP licensing strategy</h3>



<p class="wp-block-paragraph">Value sits in the terms, not the grant. Three checks follow.</p>



<p class="wp-block-paragraph">– Read your licences for the clauses that would be litigated: what counts as breach, what happens to royalties when it occurs, and which fields are in and out.</p>



<p class="wp-block-paragraph">– If you implement standards, document your negotiation conduct now. It is the record a court will read.</p>



<p class="wp-block-paragraph">– Settle with structure. The question is not what you pay but what you keep, for how long and in which markets. <a href="https://duncanbucknell.com/where-is-your-leverage-what-a-week-of-ip-disputes-teaches-about-strategy/">Where Is Your Leverage?</a> makes the same point from the enforcement side, and <a href="https://duncanbucknell.com/the-reverse-payment-you-didnt-know-you-made/">The Reverse Payment You Didn’t Know You Made</a> shows what a badly structured settlement costs later.</p>



<p class="wp-block-paragraph">An IP strategy that stops at the grant has done half the job. The other half is the deal that turns the right into revenue, or into a bill.</p>



<p class="wp-block-paragraph">Read the sources: <a href="https://www.gov.uk/government/news/government-sets-out-next-steps-on-standard-essential-patents">Government sets out next steps on standard essential patents</a>, UK Intellectual Property Office; <a href="https://www.cnbc.com/2026/10/13/delaware-jury-qualcomm-arm-license-agreement.html">Delaware jury awards Qualcomm $2 in damages, finds Arm breached license agreement</a>, CNBC; <a href="https://www.sec.gov/Archives/edgar/data/0001819576/000110465926115672/tm2627557d1_ex99-1.htm">Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics</a>, Liquidia Corporation.</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">16005</post-id>	</item>
		<item>
		<title>Who keeps the profit when AI makes the product? The trade secret test for your AI strategy</title>
		<link>https://duncanbucknell.com/who-keeps-the-profit-when-ai-makes-the-product-the-trade-secret-test-for-your-ai-strategy/</link>
		
		<dc:creator><![CDATA[Duncan]]></dc:creator>
		<pubDate>Wed, 14 Oct 2026 23:30:00 +0000</pubDate>
				<category><![CDATA[Increase IP Value]]></category>
		<category><![CDATA[Inform and improve your IP Strategy]]></category>
		<category><![CDATA[Inventions & Patents]]></category>
		<category><![CDATA[Trade Secrets]]></category>
		<guid isPermaLink="false">https://duncanbucknell.com/?p=15957</guid>

					<description><![CDATA[If AI collapses the cost of making your product, the question is no longer how cheaply you can make it. It is what stops a competitor making the same thing. That is a trade secret and patent question, and most AI strategies never get to it. A Bain &#38; Company analysis puts a number on what is at stake. It models US$4.7 trillion of profit moving across the economy between 2025 and... <a class="read-more" href="https://duncanbucknell.com/who-keeps-the-profit-when-ai-makes-the-product-the-trade-secret-test-for-your-ai-strategy/">Read More</a>]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">If AI collapses the cost of making your product, the question is no longer how cheaply you can make it. It is what stops a competitor making the same thing. That is a trade secret and patent question, and most AI strategies never get to it.</p>



<p class="wp-block-paragraph">A Bain &amp; Company analysis puts a number on what is at stake. It models US$4.7 trillion of profit moving across the economy between 2025 and 2035. Only about a quarter of that is productivity. The rest is innovation and market share changing hands. The authors&#8217; framing is blunt: &#8220;The Internet was a distribution technology. AI is a production technology.&#8221; The internet changed how products reached customers. AI changes how the product itself is made – the analysis, the diagnosis, the code, the physical work.</p>



<p class="wp-block-paragraph">Their prescription is to move early, build data no one else has, and rewire workflows so that &#8220;the data you build, the signals you watch, and the recursive improvement that compounds with every interaction become proprietary intelligence.&#8221;</p>



<p class="wp-block-paragraph"><strong>Proprietary only if you keep it that way</strong></p>



<p class="wp-block-paragraph">&#8220;Proprietary&#8221; is doing a lot of work in that sentence. Data and workflows are not owned in the way a building is owned. They are protected, if at all, as trade secrets – and a trade secret only exists while it is actually secret and you can show the steps you took to keep it so. The moment the profit shift starts, three things test that:</p>



<p class="wp-block-paragraph">– Vendors and platforms. Your AI workflow runs on someone else&#8217;s model, cloud and tooling. Whether the data and the improvements it generates stay yours is decided by the contract terms, not by the fact that you generated them.<br>– People. The engineers who rewired the workflow can leave. What they carry in their heads is not a trade secret unless the documented process, and the confidentiality obligations around it, say otherwise.<br>– Copying. Bain&#8217;s &#8220;Rewired&#8221; cluster – pharma, healthcare, aerospace, enterprise software – is where incumbents and new entrants fight over US$1.5 trillion. In those sectors, a genuinely new AI-enabled method of producing a result is often patentable. A patent is the only right that stops a rival who reaches the same method independently.</p>



<p class="wp-block-paragraph">The strategic move is to decide, for each piece of the new production layer, which protection fits: secrecy for the data and the operating know-how that cannot be reverse-engineered, patents for the methods that can. I set out that choice in <a href="https://duncanbucknell.com/patent-or-trade-secret-match-your-ip-protection-to-how-long-the-value-lasts/">Patent or trade secret? Match your IP protection to how long the value lasts</a>. The productivity quarter of Bain&#8217;s number is the part every competitor gets too, which is the trap described in <a href="https://duncanbucknell.com/is-your-ai-strategy-just-a-faster-way-to-stand-still/">Is Your AI Strategy Just a Faster Way to Stand Still?</a>. The other three quarters go to whoever owns something the others cannot copy – the argument in <a href="https://duncanbucknell.com/ai-isnt-your-advantage-your-ip-strategy-is/">AI Isn&#8217;t Your Advantage – Your IP Strategy Is</a>.</p>



<p class="wp-block-paragraph">For a board, the question to add to the AI paper is simple. Of the data, workflows and methods this investment will create, which will we be able to stop others using, and what have we done to make that true.</p>



<p class="wp-block-paragraph">Read the article: <a href="https://www.bain.com/insights/ai-puts-4-7-trillion-at-stake/">AI Will Shift $4.7 Trillion in Profits. What&#8217;s Your Stake?</a>, Bain &amp; Company.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">15957</post-id>	</item>
		<item>
		<title>Who Gets to Scale It? What China&#8217;s Energy Plans Say About Your Patent Filing Strategy</title>
		<link>https://duncanbucknell.com/who-gets-to-scale-it-what-chinas-energy-plans-say-about-your-patent-filing-strategy/</link>
		
		<dc:creator><![CDATA[Duncan]]></dc:creator>
		<pubDate>Sun, 11 Oct 2026 23:30:00 +0000</pubDate>
				<category><![CDATA[Develop IP]]></category>
		<category><![CDATA[Increase IP Value]]></category>
		<category><![CDATA[Inventions & Patents]]></category>
		<category><![CDATA[Product Strategy]]></category>
		<category><![CDATA[Pursue Excellence]]></category>
		<category><![CDATA[Strategic Advice]]></category>
		<guid isPermaLink="false">https://duncanbucknell.com/?p=15902</guid>

					<description><![CDATA[There are two ways to hold a position in a technology. You can own the technology. Or you can own what it takes to build and install the technology at volume. They are not the same asset, and only one of them is scarce. China spent August publishing the second kind. A five-year plan for oil and gas targeting a broad expansion of domestic production, pipeline infrastructure and storage. A five-year plan... <a class="read-more" href="https://duncanbucknell.com/who-gets-to-scale-it-what-chinas-energy-plans-say-about-your-patent-filing-strategy/">Read More</a>]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">There are two ways to hold a position in a technology. You can own the technology. Or you can own what it takes to build and install the technology at volume. They are not the same asset, and only one of them is scarce.</p>



<p class="wp-block-paragraph">China spent August publishing the second kind. A five-year plan for oil and gas targeting a broad expansion of domestic production, pipeline infrastructure and storage. A five-year plan for coal that treats the fuel as a foundational energy source and an energy-security guarantee, pledging a peak sometime in 2026 to 2030 without naming the year. Gas elevated to an indispensable fuel for hard-to-electrify industry and, in one industry outlet&#8217;s phrase, a stabiliser for the power system. Alongside all of it, the continued build-out of the lower-carbon alternatives, and a leadership speech acknowledging that extreme weather is now a risk to the infrastructure itself.</p>



<p class="wp-block-paragraph">Read as climate policy, that looks contradictory. Read as industrial strategy, it is coherent and it is aimed at a control point. Secure the inputs, own the pipelines, the grid and the factories, and you decide the rate at which anything gets deployed – whoever invented it.</p>



<h3 class="wp-block-heading">What this means for your patent filing strategy</h3>



<p class="wp-block-paragraph">Three disciplines follow, and none of them are specific to energy.</p>



<p class="wp-block-paragraph">– File where the thing is made and installed, not only where it is sold. A patent works only where it is in force. Manufacturing capacity relocates faster than most portfolios are reviewed, and a technology built and deployed in a country you never filed in is a technology you have donated. This is the jurisdictional half of the argument I made in <a href="https://duncanbucknell.com/capacity-is-not-a-moat-what-indias-electrification-build-out-means-for-your-ip-strategy/">Capacity Is Not a Moat</a>.</p>



<p class="wp-block-paragraph">– Protect the process, not just the product. Yield, throughput, tooling, materials handling and installation method are what actually limit scale, and in most companies they exist as undocumented practice rather than as filings or controlled trade secrets. That is a decision by default.</p>



<p class="wp-block-paragraph">– Read your supply, joint venture and offtake contracts as IP instruments. Process improvements, tooling, field data and service rights are usually allocated in schedules nobody in the IP function has read. Give them away and you keep the patent while your counterparty keeps the market.</p>



<p class="wp-block-paragraph">Timing decides how much of this is still available. Rights around an infrastructure build-out are cheap before the capacity is committed and unbuyable afterwards, which is the cost of waiting I set out in <a href="https://duncanbucknell.com/why-wait-and-see-is-becoming-the-most-expensive-ip-decision-you-can-make/">Why &#8220;Wait and See&#8221; Is Becoming the Most Expensive IP Decision You Can Make</a>.</p>



<p class="wp-block-paragraph">The prize is the position Google holds in AI compute, where rivals must keep coming back for the underlying technology, as I described in <a href="https://duncanbucknell.com/the-cash-behind-the-compute/">The Cash Behind the Compute</a>. So the question for your next board paper is not whether your invention is better than the alternatives. It is who will be able to build it at scale, in which country, under whose contracts – and what you own in that chain.</p>



<p class="wp-block-paragraph">Read the article: <a href="https://www.carbonbrief.org/china-briefing-20-august-2026-oil-and-gas-plan-xi-on-climate-change-coal-five-year-plan/">China Briefing 20 August 2026: Oil and gas plan | Xi on climate change | Coal five-year plan</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">15902</post-id>	</item>
	</channel>
</rss>